Dow Down 1.40% Nasdaq Down 1.59%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.65 Down 0.07(1.88%) 4:00PM EDT
Prev Close:3.72
Open:3.72
Bid:N/A
Ask:3.71 x 1500
1y Target Est:6.75
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.63 - 3.76
52wk Range:3.04 - 7.35
Volume:951,235
Avg Vol (3m):551,617
Market Cap:339.87M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMMUDown 1.88%339.87M
BIIBDown 2.21%76.39B
GSKDown 0.15%110.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.48
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback